What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink

Overview of attention for article published in Alzheimer's Research & Therapy, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog

twitter: 7 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 58 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 7,343 followers.

A study examining the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England. Code: https://t.co/L8aYu9Mp0d. Paper: https://t.co/pKp3C5doQY. 5/7

28 Mar 2019

Reply Repost Favourite

This will be of some interest @alzheimerssoc given your previous work to challenge to NICE around 'appropriate' use of cholinesterases in dementia. https://t.co/hBIIp40lz7

15 Jun 2018

Reply Repost Favourite

Excellent work Venexia supported by the The PerrosTrust and work that had not been scrutinised properly to this extent & an excellent contribution to your thesis that blossoms by the day! @AlzheimersBRACE @alzheimerssoc @ARUKnews https://t.co/hBIIp40lz

15 Jun 2018

Reply Repost Favourite

What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink. https://t.co/UCANsEKVE9

31 May 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.